Greece: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Greece

In 2022, the Greek prophylactic medicaments containing insulin market decreased by -0.5% to $X, falling for the second consecutive year after two years of growth. Overall, the total consumption indicated resilient growth from 2012 to 2022: its value increased at an average annual rate of +5.5% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -1.6% against 2020 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Greece

In value terms, prophylactic medicaments containing insulin production stood at $X in 2022 estimated in export price. Overall, the total production indicated a strong expansion from 2012 to 2022: its value increased at an average annual rate of +5.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -0.2% against 2020 indices. The most prominent rate of growth was recorded in 2013 with an increase of 22% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2020; afterwards, it flattened through to 2022.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Greece

In 2022, exports of medicaments containing insulin but not antibiotics in measured doses from Greece skyrocketed to X tons, with an increase of 51% against the year before. In general, exports posted a significant increase. The most prominent rate of growth was recorded in 2013 with an increase of 208%. The exports peaked in 2022 and are expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. Over the period under review, exports enjoyed a significant increase. The pace of growth was the most pronounced in 2013 with an increase of 308% against the previous year. Over the period under review, the exports reached the maximum in 2022 and are likely to see gradual growth in the immediate term.

Exports by Country

Cyprus (X tons) was the main destination for prophylactic medicaments containing insulin exports from Greece, with a 67% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Cyprus exceeded the volume sent to the second major destination, the UK (X tons), threefold.

From 2012 to 2022, the average annual growth rate of volume to Cyprus amounted to +46.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: the UK (+75.0% per year) and Denmark (+41.2% per year).

In value terms, the largest markets for prophylactic medicaments containing insulin exported from Greece were Cyprus ($X), Denmark ($X) and the UK ($X).

The UK, with a CAGR of +80.6%, saw the highest growth rate of the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, increasing by 5.8% against the previous year. Over the period under review, export price indicated temperate growth from 2012 to 2022: its price increased at an average annual rate of +4.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin export price increased by +117.1% against 2018 indices. The most prominent rate of growth was recorded in 2019 when the average export price increased by 54%. The export price peaked in 2022 and is likely to see gradual growth in the near future.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Denmark ($X per ton), while the average price for exports to Cyprus ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (+7.2%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Greece

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -15.5% to X tons, falling for the second year in a row after three years of growth. Overall, imports, however, showed a strong increase. The most prominent rate of growth was recorded in 2016 with an increase of 66%. Over the period under review, imports attained the peak figure at X tons in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports rose remarkably to $X in 2022. Over the period under review, total imports indicated a buoyant expansion from 2012 to 2022: its value increased at an average annual rate of +5.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +59.8% against 2019 indices. The pace of growth was the most pronounced in 2013 when imports increased by 47% against the previous year. Over the period under review, imports reached the maximum in 2022 and are likely to see steady growth in the near future.

Imports by Country

France (X tons), Germany (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Greece, together comprising 100% of total imports.

From 2012 to 2022, the biggest increases were recorded for France (with a CAGR of +23.0%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Greece were Denmark ($X), France ($X) and Germany ($X), together comprising 100% of total imports.

Denmark, with a CAGR of +11.6%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, growing by 29% against the previous year. Over the period under review, the import price, however, recorded a pronounced reduction. The growth pace was the most rapid in 2021 when the average import price increased by 50%. Over the period under review, average import prices attained the maximum at $X per ton in 2013; however, from 2014 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+0.1%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :